PBI-Gordon Companies Acquires TriviumVet, Expanding Portfolio of Innovative Treatments in Pet Health
PBI-Gordon Companies, Inc., an organization that inspires innovations for green spaces, pets, and people, announces the strategic acquisition of TriviumVet®, a leading research and development company advancing innovative treatments for chronic conditions in cats and dogs. The move is the largest transaction in the company's 77-year history and includes the addition of an innovative new product, Felycin®-CA1, to the PRN® Pharmacal portfolio of products.
A Silent Exodus—Veterinarians Among Thousands Leaving the USDA
In a quiet but sweeping shift within the U.S. Department of Agriculture (USDA), more than 15,000 employees have opted for financial incentive programs designed to reduce the federal workforce. Among them are hundreds of veterinarians—public health guardians whose work is essential to protecting animal welfare, ensuring food safety, and responding to disease outbreaks like avian influenza.
Proposed “Skinny Budget” Federal Budget Cuts Could Hit Veterinary Professionals Hard
A newly released federal budget proposal for the 2026 fiscal year calls for $163 billion in cuts to non-defense discretionary spending. While defense and border security are set to see significant funding increases — 13% and 65% respectively — most other areas face steep reductions, including programs vital to veterinary medicine, research, and animal and public health.
Fashion and Self-Expression: Scrubs as a Canvas for Personality
Unlike traditional office jobs where clothing might be more restrictive, veterinary medicine allows for a little more freedom in how you present yourself. Scrubs—though often seen as a uniform—serve as a canvas for expressing your personality and mood. Whether you love the bold, bright patterns of animal prints or prefer the sleek minimalism of solid-colored scrubs, what you wear in the clinic is an extension of your identity.
Real Talk: Parenting in Vet Med – What No One Prepares You For
Being a parent is hard. Being a veterinary professional is hard. Doing both at once? That’s a whole different level of mental gymnastics, emotional endurance, and logistical chaos. Brought to you by PRN Pharmacal, maker of KBro Vet CA-1, the first FDA conditionally approved medication for canine epilepsy.
FDA Approves Otiserene® for Treatment of Canine Otitis Externa
Dechra announces the recent FDA approval of Otiserene® (marbofloxacin, terbinafine, and dexamethasone otic suspension) to treat otitis externa in dogs. It is the first single-dose, long-acting otitis externa product to leverage the powerful antibiotic marbofloxacin.